NCT02812992View on ClinicalTrials.gov

Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 29, 2020

Study Completion Date

February 28, 2021

Conditions
Adenocarcinoma Pancreas
Interventions
DRUG

Nab-paclitaxel

DRUG

Gemcitabine

OTHER

Best Supportive Care

Trial Locations (1)

68167

Universitätsklinikum Mannheim II. Medizinische Klinik, Mannheim

All Listed Sponsors
lead

AIO-Studien-gGmbH

OTHER

NCT02812992 - Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients | Biotech Hunter | Biotech Hunter